Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Perioperative durvalumab plus FLOT improves OS in patients with resectable gastric or GEJ adenocarcinoma
Дата публикации: 15-09-2026 07:09:00

Findings from the final overall survival analysis of the MATTERHORN study

Основное содержимое страницы с новостью.

Subscribe to ESMO newsletter

Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH

© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Perioperative durvalumab continues to show clinical benefit in patients with resectable stage IIA to IIIB NSCLC09.2717-09-2026
2FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer5508-07-2026
3EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin0519-06-2026
4Comprehensive genomic profiling with subsequent molecularly guided therapy improves outcomes over platinum-based chemotherapy in previously untreated, unfavourable CUP016.4122-09-2026
5Neoadjuvant Serplulimab with S-1 Plus Oxaliplatin Followed by Adjuvant Serplulimab Significantly Improves EFS in PD-L1-positive, Resectable Gastric or GEJ Adenocarcinoma5730-06-2026
6Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer08.4218-08-2026
7Tebentafusp continues to provide long-term OS benefit in previously untreated patients with unresectable or metastatic uveal melanoma014.9321-09-2026
8Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases0703-07-2026
9Daraxonrasib shows antitumour activity in patients with previously treated metastatic RAS-mutated NSCLC015.8810-09-2026
10Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer—Reply06.3318-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.22. Источник: www.esmo.org.